ELDA has developed a clinically validated system that combines EEG-fMRI data, providing a solution for people with epilepsy and opening the door for research into additional brain disorders.ELDA's medical diagnostic system aims to revolutionize the way neurology patients are diagnosed.

The company has screened over 300 patients at the Tel Aviv Sourasky Medical Center, with substantial accuracy, obtained FDA pre-submission approval, and is ready for deployment in several epilepsy clinical centers worldwide.